共 50 条
Bone health in cancer: ESMO Clinical Practice Guidelines
被引:289
|作者:
Coleman, R.
[1
]
Hadji, P.
[2
,3
]
Body, J-J
[4
]
Santini, D.
[5
]
Chow, E.
[6
]
Terpos, E.
[7
]
Oudard, S.
[8
]
Bruland, O.
[9
,10
]
Flamen, P.
[11
]
Kurth, A.
[12
,13
]
Van Poznak, C.
[14
]
Aapro, M.
[15
]
Jordan, K.
[16
]
机构:
[1] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England
[2] Frankfurt Ctr Bone Hlth, Frankfurt, Germany
[3] Philipps Univ Marburg, Marburg, Germany
[4] Univ Libre Bruxelles, CHU Brugmann, Brussels, Belgium
[5] Univ Campus Biomed, Med Oncol Dept, Rome, Italy
[6] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[7] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece
[8] Paris Descartes Univ, Georges Pompidou Hosp, Dept Med Oncol, Paris, France
[9] Univ Oslo, Inst Clin Med, Oslo, Norway
[10] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway
[11] Univ Libre Bruxelles, Inst Jules Bordet, Dept Nucl Med, Brussels, Belgium
[12] Community Clin Middle Rhine, Dept Orthopaed & Trauma Surg, Campus Kemperhof, Koblenz, Germany
[13] Univ Med Mainz, Major Teaching Hosp, Mainz, Germany
[14] Univ Michigan, Ann Arbor, MI 48109 USA
[15] Genolier Canc Ctr, Genolier, Switzerland
[16] Heidelberg Univ, Dept Med Hematol Oncol & Rheumatol 5, Heidelberg, Germany
关键词:
bone metastases;
cancer treatment-induced bone loss;
bone-targeted agents;
Clinical Practice Guidelines;
diagnosis;
treatment;
follow-up;
EARLY BREAST-CANCER;
ZOLEDRONIC ACID;
MULTIPLE-MYELOMA;
DOUBLE-BLIND;
SOLID TUMORS;
OPEN-LABEL;
DENOSUMAB;
METASTASES;
PHASE-3;
SURVIVAL;
D O I:
10.1016/j.annonc.2020.07.019
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
[No abstract available]
引用
收藏
页码:1650 / 1663
页数:14
相关论文